Filing Details

Accession Number:
0000905718-20-000119
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-12 19:24:36
Reporting Period:
2020-02-10
Accepted Time:
2020-02-12 19:24:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1504167 Biopharmx Corp BPMX Pharmaceutical Preparations (2834) 593843182
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1800690 Tardimed Sciences Llc 50 Tice Boulevard, Suite A26
Woodcliff Lake NJ 07677
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.01 Per Share Acquisiton 2020-02-10 2,255,336 $0.01 2,255,336 No 4 X Indirect See Footnote
Common Stock, Par Value $0.01 Per Share Disposition 2020-02-10 55,008 $0.01 2,200,328 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Indirect See Footnote
No 4 S Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.01 Per Share Warrant (right to buy) Disposition 2020-02-10 2,225,336 $0.00 2,255,336 $0.01
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-01-28 2022-07-28 No 4 X Indirect
Footnotes
  1. The reported securities are held by Timber Pharmaceuticals LLC, a Delaware limited liability company ("Timber"). TardiMed Sciences LLC, a Connecticut limited liability company (the "Reporting Person"), owns a 90% interest in Timber. The Reporting Person disclaims beneficial ownership of the BioPharmX Corporation ("BioPharmX") common stock underlying the reported securities held by Timber except to the extent of its pecuniary interest therein.
  2. On February 10, 2020, Timber exercised a warrant to purchase 2,255,336 shares of common stock, par value $0.01 per share (the "Warrant Shares"), of BioPharmX. Timber paid the exercise price on a cashless basis, resulting in BioPharmX's withholding of 55,008 of the Warrant Shares to pay the exercise price and issuing the remaining 2,200,328 Warrant Shares to Timber.